• Publications
  • Influence
Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
PURPOSE To confirm the efficacy of a risk-adapted treatment approach for patients with clinical stage I seminoma. The aim was to reduce both the risk of relapse and the proportion of patientsExpand
  • 93
  • 4
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG).
OBJECTIVE To describe the clinical characteristics and treatment results obtained with the application of a homogeneous treatment protocol in 1490 patients with germ-cell tumours (GCT) registered inExpand
  • 111
  • 2
Parasitism of Bactrocera oleae (Diptera; Tephritidae) by Psyttalia concolor (Hymenoptera; Braconidae) in the Balearic Islands (Spain)
Psyttalia concolor (Hymenoptera; Braconidae) was introduced to Spain in the early 1970s to control the olive fruit fly Bactrocera oleae. Previous studies showed that P. concolor was poorly adapted toExpand
  • 21
  • 2
Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours.
BACKGROUND The Spanish Germ Cell Group is composed of 60 centres. Our challenge was to define a surveillance protocol that would be safe and suitable regardless of population size or geographicExpand
  • 60
  • 1
Note:Capparimyia savastani (Martelli, 1911): A new record of tephritidae of economic significance for Spain
During a trial in Majorca (Balearic Islands) conducted in 2007 for the detection of parasitoids of the olive flyBactrocera oleae by using yellow sticky traps, a single female of theExpand
  • 4
  • 1
Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a
Concurrent chemoradiotherapy (CCR) followed or preceded by full-dose chemotherapy seems to be a standard treatment for unresectable non-small cell lung cancer (NSCLC). Gemcitabine is a strongExpand
  • 19
Postchemotherapy resections of residual masses from metastatic nonseminomatous testicular germ cell tumors. A Spanish Germ Cell Group study
4525 Background: After chemotherapy for metastatic testicular tumors masses may remain. We analyze factors influencing histology and long-term evolution of patients with post-chemotherapy residualExpand
  • 4
Phase II multicentric study of concurrent chemoradiation (CCR) with biweekly gemcitabine after induction chemotherapy with cisplatin and gemcitabine in unresectable stage III non small cell lung
7322 Background: CCR in unresectable NSCLC has been superior to sequential approach in several studies. However, concurrence often precludes administration of full-dose chemotherapy. So, inductionExpand
  • 5
Risk adapted surveillance for stage I non-seminomatous testicular tumors (NSGCT). Results of a prospective multicenter study.
4524 Background: Management of stage I NSGCT is controversial. Our challenge in the Spanish Germ Cell Group composed of 60 hospitals was to reduce morbidity through a risk adapted surveillanceExpand
  • 1
La república de treballadors